天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Home Cart 0 Sign in  

[ CAS No. 10397-13-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 10397-13-4
Chemical Structure| 10397-13-4
Structure of 10397-13-4 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 10397-13-4 ]

Related Doc. of [ 10397-13-4 ]

Alternatived Products of [ 10397-13-4 ]
Product Citations

Product Details of [ 10397-13-4 ]

CAS No. :10397-13-4 MDL No. :MFCD05022359
Formula : C8H9Cl2N3O Boiling Point : No data available
Linear Structure Formula :- InChI Key :OXCOCPRVQUEIOL-UHFFFAOYSA-N
M.W : 234.08 Pubchem ID :2772068
Synonyms :

Calculated chemistry of [ 10397-13-4 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 14
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.5
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 57.78
TPSA : 38.25 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.16 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.45
Log Po/w (XLOGP3) : 2.21
Log Po/w (WLOGP) : 1.24
Log Po/w (MLOGP) : 1.06
Log Po/w (SILICOS-IT) : 2.2
Consensus Log Po/w : 1.83

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.93
Solubility : 0.272 mg/ml ; 0.00116 mol/l
Class : Soluble
Log S (Ali) : -2.65
Solubility : 0.527 mg/ml ; 0.00225 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.08
Solubility : 0.196 mg/ml ; 0.000836 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.09

Safety of [ 10397-13-4 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P305+P351+P338 UN#:
Hazard Statements:H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 10397-13-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 10397-13-4 ]

[ 10397-13-4 ] Synthesis Path-Downstream   1~1

  • 1
  • [ 10397-13-4 ]
  • [ 127561-18-6 ]
  • [ 833472-81-4 ]
YieldReaction ConditionsOperation in experiment
With potassium carbonate; In ethanol; at 78.0℃; for 8.0h; A mixture of 4, 6-DICHLORO-2-MORPHOLINOPYRIMIDINE (468 mg, 2. 0 mmol), 4- (6- TRIFLUOROMETHYL-2-PYRIDYL) piperazine (462 mg, 2. 0 mmol), potassium carbonate (345 mg, 2. 5 mmol) and ETOH (10 mL) is heated at 78C for 8 hours. The mixture is cooled, diluted with water (20 mL) and extracted with EtOAc (3 x 25 mL). The combined organics are washed with brine (25 mL), dried (MGS04) and concentrated under reduced pressure. The residue is purified by flash chromatography on silica gel (80% hexane/20% ether) to give the title compound.
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Pharmaceutical Intermediates of
[ 10397-13-4 ]

Buparlisib Intermediates

Chemical Structure| 10244-24-3

[ 10244-24-3 ]

4,4'-(6-Chloropyrimidine-2,4-diyl)dimorpholine

Chemical Structure| 944401-56-3

[ 944401-56-3 ]

5-Bromo-4-(trifluoromethyl)pyridin-2-amine

Chemical Structure| 106447-97-6

[ 106447-97-6 ]

2-Amino-4-(trifluoromethyl)pyridine

Chemical Structure| 73183-34-3

[ 73183-34-3 ]

4,4,4',4',5,5,5',5'-Octamethyl-2,2'-bi(1,3,2-dioxaborolane)

Chemical Structure| 105-53-3

[ 105-53-3 ]

Diethyl malonate

Related Functional Groups of
[ 10397-13-4 ]

Chlorides

Chemical Structure| 10397-15-6

[ 10397-15-6 ]

4,6-Dichloro-N-methylpyrimidin-2-amine

Similarity: 0.77

Chemical Structure| 10244-24-3

[ 10244-24-3 ]

4,4'-(6-Chloropyrimidine-2,4-diyl)dimorpholine

Similarity: 0.77

Chemical Structure| 23631-02-9

[ 23631-02-9 ]

4-Chloro-N,N-dimethylpyrimidin-2-amine

Similarity: 0.67

Chemical Structure| 57473-32-2

[ 57473-32-2 ]

5,7-Dichloroimidazo[1,2-a]pyrimidine

Similarity: 0.65

Chemical Structure| 22404-46-2

[ 22404-46-2 ]

4-Chloro-N-methylpyrimidin-2-amine

Similarity: 0.63

Related Parent Nucleus of
[ 10397-13-4 ]

Morpholines

Chemical Structure| 10244-24-3

[ 10244-24-3 ]

4,4'-(6-Chloropyrimidine-2,4-diyl)dimorpholine

Similarity: 0.77

Chemical Structure| 57356-66-8

[ 57356-66-8 ]

4-(Pyrimidin-2-yl)morpholine

Similarity: 0.73

Chemical Structure| 663194-10-3

[ 663194-10-3 ]

4-(4-Bromopyrimidin-2-yl)morpholine

Similarity: 0.67

Chemical Structure| 19810-79-8

[ 19810-79-8 ]

2-Morpholinopyrimidin-4-ol

Similarity: 0.66

Chemical Structure| 861031-56-3

[ 861031-56-3 ]

2-Amino-4-morpholin-4-yl-pyrimidine

Similarity: 0.61

Pyrimidines

Chemical Structure| 10397-15-6

[ 10397-15-6 ]

4,6-Dichloro-N-methylpyrimidin-2-amine

Similarity: 0.77

Chemical Structure| 10244-24-3

[ 10244-24-3 ]

4,4'-(6-Chloropyrimidine-2,4-diyl)dimorpholine

Similarity: 0.77

Chemical Structure| 57356-66-8

[ 57356-66-8 ]

4-(Pyrimidin-2-yl)morpholine

Similarity: 0.73

Chemical Structure| 23631-02-9

[ 23631-02-9 ]

4-Chloro-N,N-dimethylpyrimidin-2-amine

Similarity: 0.67

Chemical Structure| 663194-10-3

[ 663194-10-3 ]

4-(4-Bromopyrimidin-2-yl)morpholine

Similarity: 0.67

; ;